Determining the Optimal Timing of Fruit Harvest in Transgenic Tomato Expressing F1-V, a Candidate Subunit Vaccine against Plague

Abstract

Changes in the amounts of F1-V, an antigen fusion protein and a candidate subunit vaccine against plague, and total soluble protein (TSP) in green fruit of transgenic tomato plants were investigated to identify the optimum harvest timing to maximize the F1-V yields. Two T2 progenies of the transgenic plant, ‘22.11.21’ and ‘22.11.5’, were grown. The F1-V concentration rapidly decreased at the beginning of the green stage and decreased to less than 5% of the initial concentration at the late green stage in ‘22.11.21’. The F1-V concentration also decreased as fruit size increased in ‘22.11.5’, but the pattern of the decrease was linear and different from that in ‘22.11.21’. The concentration of TSP also decreased with fruit growing in both plants. When calculated on a whole fruit basis, the F1-V content linearly decreased with increasing fruit size in ‘22.11.21’. In ‘22.11.5’, the F1-V content per fruit also tended to decrease from the middle to late green stage. Based on these observations, collecting small green fruits without pruning was proposed as a harvest practice that may maximize the F1-V yields. Thus, the optimum protocols for harvesting and pruning for plant-made pharmaceutical production may be substantially different from those currently used in commercial hydroponic greenhouses for fresh market tomato.